Free Trial

NRx Pharmaceuticals (NRXP) Competitors

$3.83
-0.12 (-3.04%)
(As of 05/28/2024 ET)

NRXP vs. HOFV, ABEO, RIGL, ALIM, PRQR, CNTX, SGMT, CYBN, RAPT, and INCR

Should you be buying NRx Pharmaceuticals stock or one of its competitors? The main competitors of NRx Pharmaceuticals include Hall of Fame Resort & Entertainment (HOFV), Abeona Therapeutics (ABEO), Rigel Pharmaceuticals (RIGL), Alimera Sciences (ALIM), ProQR Therapeutics (PRQR), Context Therapeutics (CNTX), Sagimet Biosciences (SGMT), Cybin (CYBN), RAPT Therapeutics (RAPT), and InterCure (INCR).

NRx Pharmaceuticals vs.

NRx Pharmaceuticals (NASDAQ:NRXP) and Hall of Fame Resort & Entertainment (NASDAQ:HOFV) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, community ranking, institutional ownership, valuation, analyst recommendations, risk and media sentiment.

4.3% of NRx Pharmaceuticals shares are owned by institutional investors. Comparatively, 3.6% of Hall of Fame Resort & Entertainment shares are owned by institutional investors. 21.1% of NRx Pharmaceuticals shares are owned by company insiders. Comparatively, 59.9% of Hall of Fame Resort & Entertainment shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NRx Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Hall of Fame Resort & Entertainment
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Hall of Fame Resort & Entertainment received 2 more outperform votes than NRx Pharmaceuticals when rated by MarketBeat users. However, 100.00% of users gave NRx Pharmaceuticals an outperform vote while only 90.00% of users gave Hall of Fame Resort & Entertainment an outperform vote.

CompanyUnderperformOutperform
NRx PharmaceuticalsOutperform Votes
7
100.00%
Underperform Votes
No Votes
Hall of Fame Resort & EntertainmentOutperform Votes
9
90.00%
Underperform Votes
1
10.00%

NRx Pharmaceuticals has higher earnings, but lower revenue than Hall of Fame Resort & Entertainment. NRx Pharmaceuticals is trading at a lower price-to-earnings ratio than Hall of Fame Resort & Entertainment, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NRx PharmaceuticalsN/AN/A-$30.15M-$3.14-1.25
Hall of Fame Resort & Entertainment$24.13M0.73-$68.68M-$10.78-0.25

NRx Pharmaceuticals has a net margin of 0.00% compared to Hall of Fame Resort & Entertainment's net margin of -256.43%. NRx Pharmaceuticals' return on equity of 0.00% beat Hall of Fame Resort & Entertainment's return on equity.

Company Net Margins Return on Equity Return on Assets
NRx PharmaceuticalsN/A N/A -260.31%
Hall of Fame Resort & Entertainment -256.43%-45.50%-13.92%

In the previous week, NRx Pharmaceuticals and NRx Pharmaceuticals both had 3 articles in the media. NRx Pharmaceuticals' average media sentiment score of 1.42 beat Hall of Fame Resort & Entertainment's score of 1.29 indicating that NRx Pharmaceuticals is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
NRx Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hall of Fame Resort & Entertainment
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

NRx Pharmaceuticals has a beta of 1.15, suggesting that its share price is 15% more volatile than the S&P 500. Comparatively, Hall of Fame Resort & Entertainment has a beta of 1.85, suggesting that its share price is 85% more volatile than the S&P 500.

Summary

NRx Pharmaceuticals beats Hall of Fame Resort & Entertainment on 7 of the 13 factors compared between the two stocks.

Get NRx Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for NRXP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NRXP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NRXP vs. The Competition

MetricNRx PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$41.84M$6.63B$4.94B$8.08B
Dividend YieldN/A2.77%2.80%3.96%
P/E Ratio-1.2511.40129.4015.01
Price / SalesN/A241.722,531.8372.77
Price / CashN/A20.5032.6028.77
Price / Book-2.835.854.954.39
Net Income-$30.15M$138.90M$103.73M$213.15M
7 Day Performance1.30%-2.44%-1.00%-0.80%
1 Month Performance10.45%1.44%3.41%3.27%
1 Year Performance-94.41%-3.99%5.15%7.56%

NRx Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HOFV
Hall of Fame Resort & Entertainment
0 of 5 stars
$2.71
-9.1%
N/A-60.4%$17.68M$24.13M-0.2598Positive News
Gap Down
High Trading Volume
ABEO
Abeona Therapeutics
4.4237 of 5 stars
$4.06
-2.6%
$21.00
+417.2%
+29.3%$167.22M$3.50M-1.27N/AShort Interest ↓
Positive News
RIGL
Rigel Pharmaceuticals
2.4668 of 5 stars
$0.91
flat
$5.81
+540.5%
-31.3%$159.18M$116.88M-7.56147Positive News
ALIM
Alimera Sciences
3.554 of 5 stars
$2.95
-1.3%
$8.00
+171.2%
+11.7%$154.55M$80.75M-1.88154Short Interest ↓
PRQR
ProQR Therapeutics
1.8933 of 5 stars
$1.88
-0.5%
$3.38
+79.5%
+9.6%$152.95M$7.05M-5.08156Positive News
CNTX
Context Therapeutics
2.2745 of 5 stars
$2.00
+2.6%
$6.00
+200.0%
+127.3%$150MN/A-1.505Short Interest ↑
Positive News
SGMT
Sagimet Biosciences
3.5876 of 5 stars
$4.82
+2.6%
$39.20
+713.3%
N/A$146.49M$2M0.008
CYBN
Cybin
1.4175 of 5 stars
$0.36
+2.9%
$5.00
+1,304.1%
N/A$146.31MN/A-1.70N/A
RAPT
RAPT Therapeutics
4.4243 of 5 stars
$4.18
-6.9%
$24.67
+490.1%
-79.5%$145.89M$1.53M-1.36126Positive News
INCR
InterCure
0 of 5 stars
$3.17
+1.3%
N/A+51.7%$144.47M$96.61M24.39370Upcoming Earnings
Short Interest ↑
Gap Up

Related Companies and Tools

This page (NASDAQ:NRXP) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners